TTR and amyloidosis: We chose two clinically relevant, pathogenic mutations in TTR (Thr80Ala) and ASS1 (frameshift at the Phe150, “Phe150fs”) genes, causing hereditary amyloid transthyretin and type I citrullinemia, respectively [33, 34].